Skip to main content
. 2010 Jan 31;10:5. doi: 10.1186/1472-6874-10-5

Table 1.

A comparison of international guidelines recommendation for preconception care among diabetes

ADA
2009
ADA
2004
NICE
2008
SIGN
2001
ADIPS
2005
Management by multidisciplinary team

Complete preconception evaluation of medical and obstetric history

Evaluation and treatment of diabetic complications

retinopathy

nephropathy

neuropathy

cardiovascular disease

hypertension
target BP should
be < 140/80

Medication review

Review all current medication

Stop Angiotensin-Converting Enzyme (ACE) inhibitors

Stop Angiotensin-II Receptor Blockers (ARB)

Stop statins

Stop diuretics

Stop β-blockers

Assessment of metabolic control

Measure Use HbA1C Use HbA1C Use HbA1C Use HbA1C Use HbA1C

Frequency of testing 1-2 monthly

Target level < 7% Up to 1% above normal value, lower if possible < 6.1% optimised HbA1C < 7%

Blood glucose management

Self monitoring targets Before meals 4.4-6.1 mmol/l, 2 hours after meal <8.6 mmol/l Between 4 and 7 mmol/L

Educate regarding hypoglycaemia awareness and management

Prescribe insulin to achieve target blood glucose levels

Use metformin as an adjunct or alternative

Folate supplementation

Commencement preconception preconception Preconception

Dose 5 mg/day 5 mg/day 5 mg/day

Duration until 12 weeks gestation until 12 weeks gestation

Preconception Counselling

should be routinely incorporated into diabetic care is essential

Advise of risk of malformation with poor metabolic control and unplanned pregnancy

Advise use of effective contraception until good glucose control is achieved before conception

Inform woman about how DM affects pregnancy and how pregnancy affects DM

Encourage smoking cessation

Encourage reduction in alcohol intake

Provide dietary advice

Advice about weight reduction Aim for a BMI < 27 Encourage weight management and exercise

Contraindications to pregnancy HbAIC > 10% Creatinine > 0.2 mmol/L

Measure thyroid function in women with Type 1 DM